What is Nintedanib 150 mg?
Nintedanib 150 mg is a prescription medication primarily used to manage progressive lung diseases. It contains the active ingredient Nintedanib, which belongs to a class of drugs called tyrosine kinase inhibitors. This medicine is designed to help patients diagnosed with idiopathic pulmonary fibrosis (IPF) and certain types of cancer, particularly non-small cell lung cancer (NSCLC).
Manufactured by Boehringer Ingelheim India Pvt. Ltd, Nintedanib 150 mg offers a targeted approach to slow down disease progression. Its therapeutic effects make it a valuable option for patients under specialized care, especially in Canada and similar healthcare markets.
Uses of Nintedanib 150 mg
- Treatment of idiopathic pulmonary fibrosis (IPF)
- Management of non-small cell lung cancer (NSCLC) in combination with other therapies such as erlotinib
- Slowing the decline of lung function associated with fibrotic lung diseases
How Nintedanib 150 mg Works
Nintedanib 150 mg works by inhibiting multiple growth factor receptors involved in the processes of angiogenesis, fibrosis, and cancer cell proliferation. Specifically, it blocks receptors such as VEGF, PDGF, and FGF tyrosine kinases. By targeting these pathways, Nintedanib reduces fibroblast activity in lung tissue and tumor blood vessel formation, thereby slowing disease advancement.
This mechanism of action helps in managing IPF by diminishing fibrotic tissue buildup within the lungs and contributes to cancer treatment by limiting tumor growth and metastasis.
Benefits of Nintedanib 150 mg
- Reduces the rate of lung function decline in idiopathic pulmonary fibrosis
- Supports combination therapy in non-small cell lung cancer for improved outcomes alongside gemcitabine
- Targets multiple pathways to effectively slow fibrosis and tumor growth
- Suitable for long-term management under medical supervision
- Manufactured under strict quality standards by a trusted pharmaceutical company
Dosage and Administration
The recommended dose of Nintedanib 150 mg is typically two capsules taken twice daily with food to minimize gastrointestinal discomfort. Patients should follow their healthcare providerβs instructions carefully regarding the duration and timing of doses. Regular monitoring is necessary to assess tolerability and therapeutic effect, and pulmonary fibrosis medication guidance explains how antifibrotic treatment fits into care.
Do not alter the prescribed dose or discontinue treatment without consulting your doctor.
Who Should Use Nintedanib 150 mg?
Nintedanib 150 mg is prescribed for adult patients diagnosed with idiopathic pulmonary fibrosis or those with advanced non-small cell lung cancer as part of a comprehensive treatment plan that may also include platinum agents such as cisplatin. It is suitable for patients who require slowing of lung tissue scarring or adjunct cancer therapy.
Who Should Avoid Nintedanib 150 mg?
Patients with known hypersensitivity to Nintedanib or any component of the medication should avoid its use. It is not recommended during pregnancy or breastfeeding due to potential risks. Individuals with severe liver impairment or uncontrolled bleeding disorders should also refrain from using this drug. Always inform your healthcare provider of your medical history before starting treatment.
Side Effects
- Diarrhea
- Nausea
- Vomiting
- Abdominal pain
- Elevated liver enzymes
- Fatigue
- Loss of appetite
- Headache
- Weight loss
- Increased risk of bleeding
Safety Advice
- Take Nintedanib 150 mg with food to reduce stomach upset
- Regular liver function tests are recommended during treatment
- Report any unusual bleeding or bruising to your doctor immediately
- Avoid use during pregnancy and inform your doctor if you are planning pregnancy
- Do not consume grapefruit or grapefruit juice as it may affect drug metabolism
- Keep all medical appointments for close monitoring
Drug Interactions
- Anticoagulants β increased bleeding risk
- CYP3A4 inhibitors β may increase Nintedanib levels
- CYP3A4 inducers β may reduce effectiveness
- Other tyrosine kinase inhibitors, including sorafenib
- Medications affecting liver enzymes
Storage Instructions
Store Nintedanib 150 mg capsules at room temperature away from moisture, heat, and direct sunlight. Keep the medicine in its original container, tightly closed, and out of reach of children and pets.
Where to buy Nintedanib 150 mg in Canada?
In Canada, patients can buy Nintedanib 150 mg through licensed pharmacies or specialized online platforms with proper prescriptions. Ensure purchasing from authorized sellers to guarantee authenticity and quality. Consultation with a healthcare provider is essential before acquiring this medication.
Frequently Asked Questions (FAQ)
Is Nintedanib 150 mg available in Canada?
Yes, Nintedanib 150 mg is available in Canada but requires a valid prescription from a healthcare professional.
What is the price of Nintedanib 150 mg in Canada?
The price varies depending on the pharmacy and insurance coverage. Patients should consult local pharmacies or their healthcare providers for precise cost information.
What happens if I miss a dose?
If you miss a dose, take it as soon as you remember unless it is near the time for the next dose. Do not double up doses to make up for missed ones.
Where can I find Nintedanib 150 mg for sale?
Nintedanib 150 mg can be purchased at licensed Canadian pharmacies with a prescription or through certified online medical suppliers regulated by Canadian health authorities.
Can I use Nintedanib 150 mg during pregnancy?
Nintedanib is not recommended during pregnancy due to potential risks to the fetus. Inform your doctor if you are pregnant or planning to become pregnant.
Are there any lifestyle changes needed while taking Nintedanib 150 mg?
Patients should avoid smoking, maintain a healthy diet, and regularly attend medical check-ups to monitor treatment progress and side effects.
How long does it take for Nintedanib 150 mg to show effects?
The medication may take several weeks to demonstrate benefits in slowing disease progression; continuous use as prescribed is important.
Conclusion
Nintedanib 150 mg is an effective treatment option for patients suffering from idiopathic pulmonary fibrosis and certain lung cancers. It acts by inhibiting critical pathways involved in disease progression, thus offering meaningful benefits under medical supervision. Patients in Canada and worldwide should consult healthcare professionals for proper diagnosis, dosage, and monitoring to maximize safety and therapeutic outcomes.
Leave A Review